Selection Criteria
For further information on selection criteria, please refer to the Round 2 Funding Guidelines.
EOIs for Round 2 are now closed
Unmet Need and Impact
A proposed solution that is novel, differentiated and addresses a clearly defined public health or clinical unmet (or underserved) need. Clear articulation of the solution’s value proposition, how it could deliver meaningful population-level and/or market impact and clear competitive advantage or differentiation from current standard of care, solutions available or solutions in development.
Scientific and Technical Merit
A robust scientific rationale, clearly articulating and validating the mechanism of action of the intervention and data confirming the intervention is effective in pre-clinical models. Supportive data that demonstrate feasibility, reproducibility, and potential for production at scale.
Project Plan
A well-defined, milestone-driven project plan that aligns with the critical path towards the next key value inflection point and the broader path to market. Proposed activities are supported and justified by measurable deliverables, clear Go/No-Go decision points, identification of key risks and associated mitigation strategies, realistic timelines, and an appropriate, justified budget aligned with project scope and stage of development.
Translation and Commercialisation
A credible translation, development and commercialisation plan and path to market covering a follow-on funding/investment strategy, plans for partnerships/collaborations and a realistic strategy to advance to the next stage of development, TRL and/or value inflection point. Together with an appropriate regulatory pathway, favourable IP position and justified target market, there is evidence of a clear commercial and/or commercialisation opportunity. While some infectious disease interventions may hold uncertain commercial return, a clear mechanism and pathway to commercialisation must be evident.
Team Capability and Resources
A committed, multidisciplinary, and diverse team with the required track-record, expertise, resources, and access to required infrastructure or partners to achieve the proposed milestones and objectives of the proposed project and ultimately, position the technology as an attractive opportunity for follow-on investment.
